2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll
about
Juvenile Idiopathic Arthritis: Diagnosis and TreatmentJuvenile Idiopathic Arthritis in the Era of International Cooperation.Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis.Juvenile Idiopathic ArthritisSuccessful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based ReviewAdult Onset Still's Disease Associated with Mycoplasma pneumoniae Infection and Hemophagocytic Lymphohistiocytosis.Treatment of adult-onset still's disease: up to date.Hemophagocytic lymphohistiocytosis: an update for nephrologists.Diagnosing haemophagocytic syndrome.New frontiers in the treatment of systemic juvenile idiopathic arthritis.Macrophage activation syndrome triggered by coeliac disease: a unique case report.Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra.The clinical utility of splenic fluorodeoxyglucose uptake for diagnosis and prognosis in patients with macrophage activation syndrome.Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients.The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.Combination Immunosuppressive Therapy Including Rituximab for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adult-Onset Still's Disease.Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis.Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis.Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.Combining multiple biomarkers differentiates between active SJIA, SJIA-MAS and EBV-HLH.Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.Severe acute pancytopaenia in a patient with rheumatoid arthritis complicated by fatal invasive pulmonary aspergillosis.Efficacy of Cyclosporine in the Induction and Maintenance of Remission in a Systemic Lupus Erythematosus Patient Presenting with Macrophage-Activating Syndrome.The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.
P2860
Q28079246-25EF1FF0-CBFF-445E-BA2F-1D6D04ABD583Q30235998-2DA221F4-F605-4BB6-8603-3CDC7516ABAEQ33433845-9B6DD154-9226-4941-93BD-36228FD3AAADQ33572045-485703C4-3403-4256-A68E-103AB965B859Q37263772-28BAADA0-A5C8-403A-82F7-8359390E1E8AQ37402329-E9826B32-45D5-4860-8396-EE2D8A1352C4Q38679486-6E3CB003-983E-4108-98B7-01B544610EB1Q38813217-7D556EE9-A2E8-43CA-A57F-EAED8112EECAQ39004494-6453E113-471A-497B-91B9-B8685E643ED2Q39424746-FE0D4F04-1335-4033-B2D7-23AFEC891440Q40077192-A05EA69D-F881-482E-93D7-16B96DE6329BQ40080398-565C4255-0E18-481E-8118-61B190884E08Q40081000-ADE775B2-C9EE-4F68-9E65-BAD6643458FEQ40082328-970E63F9-8C2B-4FA6-8D30-C0CCC037E7C7Q40093291-4BB2F86C-09A7-48C1-B555-9E7C74D5CD79Q40102961-016F3208-D9EA-455A-B66C-AEBAE1401CA0Q40116584-C361ED4A-7C29-476A-926C-CD36F22641A6Q40395354-8B5923DB-6531-44EC-860A-C57AF0718DB5Q41704840-9002B91B-2F64-4066-A9F2-FCAB0A7BE86BQ42322137-1E2303F0-99A3-4A83-B121-FCABD889960DQ47150341-7385FF97-65D5-42AD-A16A-EE7A41BB64A9Q48247481-6F4CDC1D-CA1B-417B-8789-4D9E3DA36A48Q48340351-EC0D46E0-E2A7-4C14-8634-3B80BC32894CQ51705351-A11EF685-F688-4743-919D-AD49D0BFED8EQ52947070-0072F06C-E2A6-4DA7-B023-488D601FD977Q54253814-4FF70315-3992-4838-A1CC-4618F784F488Q55206915-5879DCD1-752D-4505-93FB-7F56F1AD8DD4
P2860
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
2016 Classification Criteria f ...... ional Trials Organisation Coll
@en
type
label
2016 Classification Criteria f ...... ional Trials Organisation Coll
@en
prefLabel
2016 Classification Criteria f ...... ional Trials Organisation Coll
@en
P2093
P50
P1476
2016 Classification Criteria f ...... ation Collaborative Initiative
@en
P2093
Alberto Martini
Alexei A Grom
Athimalaipet V Ramanan
Carol Wallace
Childhood Arthritis and Rheumatology Research Alliance
Daniel J Lovell
Edward M Behrens
Erkan Demirkaya
Gary Sterba
Hermine I Brunner
P304
P356
10.1136/ANNRHEUMDIS-2015-208982
P407
P50
P577
2016-03-01T00:00:00Z